Genetic discovery could help guide treatment for aggressive childhood cancer
A new study could lead to improved decision making in assigning treatments for children with the aggressive cancer rhabdomyosarcoma after revealing key genetic changes underlying development of the disease.
In the largest and most comprehensive study of rhabdomyosarcoma to date, scientists found that specific genetic changes in tumours are linked to aggressiveness, early age of onset and location in the body.
All these factors affect the chances that children will survive their disease - and understanding how they are driven by a cancer's genetics could lead to new ways of tailoring treatment for each patient.
Rhabdomyosarcoma is a rare type of cancer that resembles muscle tissue and mostly affects ...











